▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4125 by analyst upside · 2026-06-27
HIMS
Hims & Hers Health, Inc.
Healthcare · Market Cap $8B · P/E 0x
ANALYST PRICE TARGET
-19.5%
implied upside to consensus target
Current Price $33.94
Consensus Target $27.32
Bull Target $39.0
Bear Target $21.0
Analysts Covering 14
ANALYST CONSENSUS - HOLD
Strong Buy
2
Buy
1
Hold
11
Sell
0
52-Week Low $13.74
52-Week High $70.43
YTD Return +1.6%
FUNDAMENTALS
Market Cap $8B
P/E Ratio (TTM) N/A
Forward P/E 38.1x
EPS (TTM) $-0.09
PEG Ratio 2.15
Dividend Yield N/A
Revenue (TTM) $2.4B
Profit Margin -0.6%
52-WEEK RANGE
52-Week Low $13.74
52-Week High $70.43
Current Price $33.94
Bear Target $21.0
Bull Target $39.0
● Now $33.94 ● Target $27.32
TRADING DATA
Avg Volume 25.6M
YTD Return +1.6%
Analyst Count 14
Consensus Hold
Upside to Target -19.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Hims & Hers Health, Inc. (HIMS) is currently trading at $33.94 with a Wall Street consensus price target of $27.32, which is 19.5% below the current price over the next 12 months. 14 analysts currently cover HIMS, with a consensus rating of Hold - 21% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $39.0, while the most cautious has a target of $21.0.

HIMS operates in the Healthcare sector with a market capitalisation of $8B. The stock is up 1.6% year-to-date and is currently trading near the lower end of its 52-week range of $13.74 – $70.43.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

TGTX -7.4%
TG Therapeutics, Inc.
$9B · P/E 19.5x · Buy
CHE -3.6%
Chemed Corporation
$6B · P/E 24.7x · Hold
QGEN +11.6%
Qiagen N.V.
$8B · P/E 20.1x · Buy
HSIC +3.7%
Henry Schein, Inc.
$10B · P/E 25.3x · Buy
LGND -8.6%
Ligand Pharmaceuticals Incorporated
$6B · P/E 39.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for HIMS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Overweight → Overweight 2026-06-18 Building track record
B of A Securities — Reiterated
Neutral → Neutral 2026-05-26 Building track record
Truist Securities — Reiterated
Hold → Hold 2026-05-22 Building track record
B of A Securities — Reiterated
Neutral → Neutral 2026-05-19 Building track record
B of A Securities — Reiterated
Neutral → Neutral 2026-05-13 Building track record
Citigroup — Reiterated
Neutral → Neutral 2026-05-12 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-05-12 43% win rate (7 calls)
BTIG reit
Neutral → Neutral 2026-05-12 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
21/30
Consensus clarity
19/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →